FIELD: medicine.
SUBSTANCE: group of inventions is based on the induction of recognising dominant and sub-dominant responses to epitopes of any antigen important for preventing or treating a chronic diseases by immunisation with pools of overlapping fragments of a desired antigen. A T cell spectrum is primed to be included both for a principal epitope recognised when using an intact molecule for immunisation and induced by a chronic infection, and for inducing a much wider and more balanced response to the number of the sub-dominant epitopes. An elicited T cell response to the sub-dominant epitopes is important to protect against the chronic disease which itself induces the response focused on the principal epitopes only.
EFFECT: group of inventions requires no advance information on the exact localisation and identity of the sub-dominant epitopes, as well as recognition thereof in the human population, and extends the range of T-cells and thereby total number of epitopes recognised by the specific T cells primed by vaccination against several principal epitopes to the variety of the epitopes of the vaccine importance.
12 cl, 13 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT STRAIN OF INFLUENZA VIRUS A/PR8-NS124-TB10_4-2A-HSPX AND METHOD FOR SPECIFIC PREVENTION OF PULMONARY TUBERCULOSIS USING MUCOSAL VACCINE BASED THEREON | 2019 |
|
RU2726106C1 |
HYBRIDISATION OF HETEROOLIGOMER MYCOBACTERIAL ANTIGENS | 2015 |
|
RU2695462C2 |
USE OF MONOMYCOLYL GLYCEROL (MMG) AS ADJUVANT | 2008 |
|
RU2479317C2 |
POLYANTIGENIC VACCINE FOR PREVENTING AND ADJUNCTIVE TREATMENT OF TUBERCULOSIS | 2019 |
|
RU2724896C1 |
MULTI-EPITOPE POLYPEPTIDE FOR IMMUNIZATION AGAINST MYCOBACTERIUM TUBERCULOSIS | 2023 |
|
RU2824195C1 |
PREVENTIVE OR THERAPEUTIC POLYEPITOPIC ANTI-TUBERCULOSIS VACCINE CONSTRUCTION PROVIDING INDUCTION OF CELLULAR IMMUNE RESPONSE OF CD4+ OR CD8+ T-LYMPHOCYTES | 2011 |
|
RU2539035C2 |
MODIFIED EPITOPES FOR AMPLIFYING RESPONSES OF CD4+ T-CELLS | 2013 |
|
RU2724994C2 |
IMMUNOREGULATORY VACCINE | 2013 |
|
RU2650709C2 |
MODULATION OF ANTIGEN IMMUNOGENICITY BY ADDITION OF EPITOPES RECOGNIZED BY NKT CELLS | 2011 |
|
RU2603075C2 |
COMPOSITION FOR STIMULATING DENDRITIC CELL MATURATION, CONTAINING HYBRID PROTEIN RV2299C/ESAT-6 | 2017 |
|
RU2733886C2 |
Authors
Dates
2013-08-20—Published
2007-06-26—Filed